Lomtegovimab
洛替韦单抗
Report date: 2026/03/23 20:03:44
Base Information
Drug NameLomtegovimab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of CologneGerman Center For Infection Research
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of Cologne
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A